Enanta Pharmaceuticals earnings were -$96.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ENTA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$22.6M, up 1.6% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, ENTA reported annual earnings of -$116.0M, with -13.3% growth.
Enanta Pharmaceuticals Earnings Reports & History FAQ
What were Enanta Pharmaceuticals's earnings last quarter?
On ENTA's earnings call on Invalid Date, Enanta Pharmaceuticals (NASDAQ: ENTA) reported Q1 2025 earnings per share (EPS) of -$1.06, up 27.89% year over year. Total ENTA earnings for the quarter were -$22.64 million. In the same quarter last year, Enanta Pharmaceuticals's earnings per share (EPS) was -$1.47.
Is Enanta Pharmaceuticals profitable or losing money?
As of the last Enanta Pharmaceuticals earnings report, Enanta Pharmaceuticals is currently losing money. Enanta Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$96.42 million, a 26.81% decrease year over year.
What was ENTA's earnings growth in the past year?
As of Enanta Pharmaceuticals's earnings date in Invalid Date, Enanta Pharmaceuticals's earnings has grown year over year. ENTA earnings in the past year totalled -$96.42 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.